Download PDF
Thromb Haemost 1999; 82(02): 165-174
DOI: 10.1055/s-0037-1615780
Research Article
Schattauer GmbH

Biochemistry and Physiology of Blood Coagulation

Kenneth G. Mann
1   University of Vermont, College of Medicine, Burlington, VT, USA
› Author Affiliations
Further Information

Publication History

Publication Date:
09 December 2017 (online)

Also available at
    Permissions and Reprints

Introduction

The biochemical investigation of a biological process can be divided into three segments. The first is the development of an inventory of the components involved in the process, the second is the establishment of the connectivity between components, and the third is the establishment of the dynamics of the processes as they occur in the living organism.

 

  • References

  • 1 Schmidt A. Neue Untersuchungen ueber die Fasserstoffesgerinnung. Pflueger’s Arch.f.ges.Physiol. 1872; 6: 413-538.
    PubMedSearch in Google Scholar
  • 2 Morawitz P. Die Chemie der Blutgerrinnung. Ergebn Physiol. 1905; 4: 307-423.
    CrossrefPubMedSearch in Google Scholar
  • 3 Patek AJ, Taylor FHL. Hemophilia II: some properties of a substance obtained from normal plasma effective in accelerating the clotting of hemophilic blood. J Clin Invest. 1937; 113-124.
    PubMedSearch in Google Scholar
  • 4 Brinkhous KM. Clotting defect in hemophilia: deficiency in a plasma factor required for platelet utilization. Proc Soc Exp Biol Med. 1947; 66: 117-120.
    CrossrefPubMedSearch in Google Scholar
  • 5 Aggeler PM, White SG, Glendenning MB. Plasma thromboplastin component (PTC) deficiency: a new disease resembling hemophilia. Proc Soc Exp Bio Med. 1952; 79: 692-694.
    CrossrefPubMedSearch in Google Scholar
  • 6 Schulman ISCH. Hemorrhagic disease in an infant due to deficiency of a previously undescribed clotting factor. Blood 1952; 7: 794-807.
    PubMedSearch in Google Scholar
  • 7 Biggs R, Douglas AS, MacFarlane RG. et al. Christmas disease: a condition previously mistaken for hemophilia. Br Med J. 1952; 2: 1378-1382.
    CrossrefPubMedSearch in Google Scholar
  • 8 Bachmann F, Duckert F, Koller K. The Stuart-Prower factor assay and its clinical significance. Thromb Diath Haemorrh. 1999; 2: 24-38.
    PubMedSearch in Google Scholar
  • 9 Alexander B, Goldstein RA, Landweher G. et al. Congenital SPCA deficiency: a hither to unrecognized coagulation defect with hemorrhage rectified by serm and serum fractions. J Clin Invest. 1951; 30: 596-608.
    CrossrefPubMedSearch in Google Scholar
  • 10 Soulier JP, Wartell O, Menache D. Caracteres differentiels des facteurs hageman et P.T.A.; role due contact dans la phase initiate de la coagulation. Rev Franc Etudes Clin Biol. 1958; 3: 363
    PubMedSearch in Google Scholar
  • 11 Botti RE, Ratnoff OD. The clot-promoting effect of soaps of long-chain saturated fatty acids. J.Clin.Invest. 1963; 42: 1569-1577.
    PubMedSearch in Google Scholar
  • 12 Owren PA. Parahaemophilia. Haemorrhagic diathesis due to absence of a previously unknown clotting factor. Lancet. 1947; 1: 446-448.
    PubMedSearch in Google Scholar
  • 13 Wright IS. The nomenclature of blood clotting factors. Thromb Diath Haemost. 1962; 7: 381-388.
    PubMedSearch in Google Scholar
  • 14 Warner ED, Brinkhous KM, Smith HP. A quantitative study of blood clotting. Am J Physiol. 1936; 114: 667-675.
    PubMedSearch in Google Scholar
  • 15 Quick AJ. On the Constitution of Prothrombin. Am J Physiol. 1999; 140: 212-220.
    PubMedSearch in Google Scholar
  • 16 Langdell RD, Wagner RH, Brinkhous KM. Effect of antihemophilic factor on one-stage clotting tests: a presumptive test for hemophilia and a single one-stage antihemophilic factor assay procedure. J Lab Clin Med. 1953; 41: 7637-7647.
    PubMedSearch in Google Scholar
  • 17 Ratnoff OD, Colpy JE. A familial hemorrhagic trait associated with a deficiency of a clot-promoting fraction of plasma. J Clin Invest. 1955; 34: 602-613.
    CrossrefPubMedSearch in Google Scholar
  • 18 Jacobsen SFM. Some data on two purified kininogens from human plasma. Br.J.Pharmacol. 1967; 29: 25
    PubMedSearch in Google Scholar
  • 19 Mandle Jr R, Coleman RW, Kaplan AP. Identification of prekallikrein and high molecular weight kininogen complex in plasma. Proc Natl Acad Sci USA. 1976; F3: 4179-4183.
    PubMedSearch in Google Scholar
  • 20 Duckert F, Jung SH, Schmerling DH. A hitherto undescribed congenital haemorrhagic diathesis probably due to fibrin stabilizing factor deficiency. Thromb Diath Haemorrh. 1961; 5: 179-186.
    PubMedSearch in Google Scholar
  • 21 Howell WH. The role of antithrombin and thromboplastin (thromboplastic substance) in the coagulation of blood. Am J Physiol. 1911; 29: 187-209.
    PubMedSearch in Google Scholar
  • 22 Broze Jr. GJ, Miletich JP. Isolation of the tissue factor inhibitor produced by HepG2 hepatoma cells. Proc Natl Acad Sci USA. 1987; 84: 1886-1890.
    CrossrefPubMedSearch in Google Scholar
  • 23 Stenflo J, Fernlund P, Egan W, Roepstorff P. Vitamin K dependent modification of glutamic acid residues in prothrombin. Proc Natl Acad Sci USA. 1974; 71: 2730-2733.
    CrossrefPubMedSearch in Google Scholar
  • 24 Kisiel W. Human plasma protein C. Isolation, characterization and mechanism of activation by alpha-thrombin. J Clin Invest. 1979; 64: 761-769.
    CrossrefPubMedSearch in Google Scholar
  • 25 DiScipio RG, Davie EW. Characterization of protein S, a gamma-carboxy-glutamic acid containing protein from bovine and human plasma. Biochem. 1979; 18: 899-904.
    CrossrefPubMedSearch in Google Scholar
  • 26 Broze GJ, Miletich J. Human Protein Z. J Clin Invest. 1984; 73: 933.
    CrossrefPubMedSearch in Google Scholar
  • 27 Esmon CT, Owen WG. Identification of an endothelial cell cofactor for thrombin catalyzed activation of protein C. Proc Natl Acad Sci USA. 1981; 78: 2249-2252.
    CrossrefPubMedSearch in Google Scholar
  • 28 MacFarlane RG. An enzyme cascade in the blood clotting mechanism, and its function as a biochemical amplifier. Nature 1964; 202: 498-499.
    CrossrefPubMedSearch in Google Scholar
  • 29 Davie EW, Ratnoff OD. Waterfall sequence for intrinsic blood clotting. Science 1964; 145: 1310-1312.
    CrossrefPubMedSearch in Google Scholar
  • 30 Osterud B, Rapaport SI. Activation of Factor IX by the reaction product of tissue Factor and Factor VII: Additional pathway for initiating blood coagulation. Proc Natl Acad Sci. 1977; 74: 5260-5260.
    CrossrefPubMedSearch in Google Scholar
  • 31 Gailani D, Broze Jr. GJ. Factor XI activation in a revised model of blood coagulation. Science 1991; 253: 909-912.
    CrossrefPubMedSearch in Google Scholar
  • 32 Ware AG, Seegers WH. Two Stage Procedure for the Quantitative Determination of Prothrombin Concentration. Am J Clin Path. 1949; 19: 471-482.
    CrossrefPubMedSearch in Google Scholar
  • 33 Seegers WH. Activation of Purified Prothrombin. Proc Soc Exptl Biol Med. 1949; 72: 677-680.
    CrossrefPubMedSearch in Google Scholar
  • 34 Tracy PB, Eide LL, Mann KG. Human prothrombinase complex assembly and function on isolated peripheral blood and cell populations. J Biol Chem. 1985; 260: 2119-2124.
    PubMedSearch in Google Scholar
  • 35 Nesheim ME, Pittman DD, Wang JH, Slonosky D, Giles AR, Kaufman RJ. The binding of 35S-labeled recombinant factor VIII to activated and unactivated human platelets. J Biol Chem. 1988; 263: 16467-16470.
    PubMedSearch in Google Scholar
  • 36 Weiss HJ, Turitto VT, Baumgartner HR. The role of shear rate and platelets in promoting fibrin formation on rabbit subendothelium:Studies utilizing patients with quantitative and qualitative platelet defects. J Clin Invest. 1986; 78: 1072
    CrossrefPubMedSearch in Google Scholar
  • 37 Bevilacqua MP, Pober JS, Majeau GR, Cotran RS, Gimbrone Jr. MA. Interleukin-1 (IL-1) induces biosynthesis and cell surface expression of procoagulant activity in human vascular endothelial cells. J Exp Med. 1984; 160: 618-623.
    CrossrefPubMedSearch in Google Scholar
  • 38 Mann K, Nesheim M, Church W, Haley P, Krishnaswamy S. Surface dependent reactions of the vitamin K-dependent enzyme complexes. Blood 1990; 76: 1-16.
    PubMedSearch in Google Scholar
  • 39 Morrissey JH, Macik BG, Neuenschwander PF, Comp PC. Quantitation of activated factor VII levels in plasma using a tissue factor mutant selectively deficient in promoting factor VII activation. Blood 1993; 81: 734-744.
    PubMedSearch in Google Scholar
  • 40 Lawson JH, Butenas S, Mann KG. The evaluation of complex-dependent alterations in human factor VIIa. J Biol Chem. 1992; 267: 4834-4843.
    PubMedSearch in Google Scholar
  • 41 Broze Jr. GJ, Girard TJ, Novotny WF. Regulation of coagulation by a multivalent Kunitz-type inhibitor. Biochemistry. 1990; 29: 7539-7546.
    CrossrefPubMedSearch in Google Scholar
  • 42 Esmon CT. The roles of protein C and thrombomodulin in the regulation of blood coagulation. J Biol Chem. 1989; 264: 4743-4746.
    PubMedSearch in Google Scholar
  • 43 Kalafatis M, Rand MD, Mann KG. The mechanism of inactivation of human factor V and human factor Va by activated protein C. J Biol Chem. 1994; 269: 31869-31880.
    PubMedSearch in Google Scholar
  • 44 Fay PJ, Smudzin TM. Characterization of the Interaction of the A2 Subunit and AI/A3-C1-C2 Dimer in Human Factor VIII. J Biol Chem. 1992; 267: 13246-13250.
    PubMedSearch in Google Scholar
  • 45 Rosenberg RD, Damus PS. The Purification and Action of Human Antithrombin-Heparin Cofactor. J Biol Chem. 1973; 248: 6490-6505.
    PubMedSearch in Google Scholar
  • 46 Marcum JA, Rosenberg RD. Anticoagulantly active heparinlike molecules from vascular tissue. Biochemistry. 1984; 23: 1730-1730.
    CrossrefPubMedSearch in Google Scholar
  • 47 Lawson JH, Kalafatis M, Stram S, Mann KG. A model for the tissue factor pathway to thrombin: 1. an empirical study. J Biol Chem. 1994; 269 (37) 23357-23366.
    PubMedSearch in Google Scholar
  • 48 van ‘t Veer C Golden NJ, Kalafatis M, Mann KG. Inhibitory mechanism of the protein C pathway on tissue factor-induced thrombin generation: synergistic effect in combination with tissue factor pathway inhibitor. J Biol Chem. 1997; 272: 7983-7994.
    CrossrefPubMedSearch in Google Scholar
  • 49 van ‘t Veer C Mann KG. Regulation of tissue factor initiated thrombin generation by the stoichiometric inhibitors tissue factor pathway inhibitor, antithrombin-III, and heparin cofactor II. J Biol Chem. 1997; 272: 4367-4377.
    CrossrefPubMedSearch in Google Scholar
  • 50 van ‘tVeer C Kalafatis M, Bertina RM, Simioni P, Mann KG. Increased tissue factor-initiated prothrombin activation as a result of the Arg506-Gln Mutation in factor VLeiden . J Biol Chem. 1997; 272: 20721-20729.
    CrossrefPubMedSearch in Google Scholar
  • 51 Jones KC, Mann KG. A model for the tissue factor pathway to thrombin: 2. a mathematical simulation. J Biol Chem. 1994; 269 (37) 23367-23373.
    PubMedSearch in Google Scholar
  • 52 Shafi T, Jeha JM, Black L, Al Douri M. Severe acquired haemophilia A treated with recombinant factor VIIa. Br J Haematol. 1997; 98: 910-912.
    CrossrefPubMedSearch in Google Scholar
  • 53 Rand MD, Lock JB. van ‘t Veer C et al. Blood clotting in minimally altered whole blood. Blood 1997; 88: 3432-3445.
    PubMedSearch in Google Scholar
  • 54 Cawthern KM, van ‘t Veer C Locke JB, DiLorenzo ME, Branda RF, Mann KG. Blood Coagulation in Hemophilia A and Hemophilia C. Blood 1998; 91: 4581-4592
    PubMedSearch in Google Scholar